Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Byar

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Cancer|September 1, 1976
Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.
Cancer|September 1, 1976
Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.
Cancer|October 1, 1978
Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.
Cancer|August 1, 1970
Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostateC E Blackard, R P Doe, G T Mellinger, et al.
The Journal of Urology|April 1, 1975
Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancerC E Blackard, D P Byar, U S Seal, et al.
Medical Instrumentation|January 1, 1979
A computerized reference laboratoryD G Makey, D K Corle, D P Byar, et al.
Cancer Treatment Reports|September 1, 1981
Proper analysis of clinical trials for malignant gliomaS B Green, D P Byar, T A Strike, et al.
Controlled Clinical Trials|February 1, 1992
Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT)M H Gail, D P Byar, T F Pechacek, et al.
The New England Journal of Medicine|October 10, 1974
Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancerC E Blackard, D P Byar, U S Seal, et al.
American Journal of Epidemiology|November 1, 1985
Estimating the population attributable risk for multiple risk factors using case-control dataP Bruzzi, S B Green, D P Byar, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cancer|September 1, 1976
Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.
Cancer|September 1, 1976
Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.
Cancer|October 1, 1978
Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancerU S Seal, R P Doe, D P Byar, et al.
Cancer|August 1, 1970
Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostateC E Blackard, R P Doe, G T Mellinger, et al.
The Journal of Urology|April 1, 1975
Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancerC E Blackard, D P Byar, U S Seal, et al.
Medical Instrumentation|January 1, 1979
A computerized reference laboratoryD G Makey, D K Corle, D P Byar, et al.
Cancer Treatment Reports|September 1, 1981
Proper analysis of clinical trials for malignant gliomaS B Green, D P Byar, T A Strike, et al.
Controlled Clinical Trials|February 1, 1992
Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT)M H Gail, D P Byar, T F Pechacek, et al.
The New England Journal of Medicine|October 10, 1974
Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancerC E Blackard, D P Byar, U S Seal, et al.
American Journal of Epidemiology|November 1, 1985
Estimating the population attributable risk for multiple risk factors using case-control dataP Bruzzi, S B Green, D P Byar, et al.
Pageof 9